BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 15766828)

  • 1. Hemodynamic and autonomic effects of smokeless tobacco in healthy young men.
    Wolk R; Shamsuzzaman AS; Svatikova A; Huyber CM; Huck C; Narkiewicz K; Somers VK
    J Am Coll Cardiol; 2005 Mar; 45(6):910-4. PubMed ID: 15766828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of hydrocortisone on sympathetic and hemodynamic responses to sympathoexcitatory manoeuvres in men.
    Heindl S; Vahlkamp K; Weitz G; Fehm HL; Dodt C
    Steroids; 2006 Mar; 71(3):206-13. PubMed ID: 16388832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of treatment on cardiovascular risk among smokeless tobacco users.
    Allen SS; Hatsukami D; Jensen J; Grillo M; Bliss R
    Prev Med; 1995 Jul; 24(4):357-62. PubMed ID: 7479625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of aldosterone on the autonomic nervous system and the baroreflex function in healthy humans.
    Heindl S; Holzschneider J; Hinz A; Sayk F; Fehm HL; Dodt C
    J Neuroendocrinol; 2006 Feb; 18(2):115-21. PubMed ID: 16420280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic and vascular effects of short-term passive smoke exposure in healthy nonsmokers.
    Hausberg M; Mark AL; Winniford MD; Brown RE; Somers VK
    Circulation; 1997 Jul; 96(1):282-7. PubMed ID: 9236446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sympathetic and haemodynamic responses to lipids in healthy human ageing.
    Florian JP; Pawelczyk JA
    Exp Physiol; 2010 Apr; 95(4):486-97. PubMed ID: 20061355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-esterified fatty acids increase arterial pressure via central sympathetic activation in humans.
    Florian JP; Pawelczyk JA
    Clin Sci (Lond); 2009 Oct; 118(1):61-9. PubMed ID: 19426144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does blockade of the renin angiotensin system affect sympathetic and blood pressure responses to amlodipine in young hypertensive patients?
    Ruzicka M; Coletta E; Leenen FH
    Am J Hypertens; 2007 Nov; 20(11):1202-8. PubMed ID: 17954368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition.
    Tank J; Schroeder C; Diedrich A; Szczech E; Haertter S; Sharma AM; Luft FC; Jordan J
    Circulation; 2003 Jun; 107(23):2949-54. PubMed ID: 12796139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate as a sympathetic marker during acute adrenergic challenge.
    Grassi G; Seravalle G; Bolla G; Quarti-Trevano F; Dell'Oro R; Arenare F; Mancia G
    J Hypertens; 2008 Jan; 26(1):70-5. PubMed ID: 18090542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of sibutramine treatment on sympathetic vasomotor tone in obese subjects.
    Heusser K; Tank J; Diedrich A; Engeli S; Klaua S; Krüger N; Strauss A; Stoffels G; Luft FC; Jordan J
    Clin Pharmacol Ther; 2006 May; 79(5):500-8. PubMed ID: 16678551
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of sympathetic modulation induced by single oral doses of mibefradil, amlodipine, and nifedipine in healthy volunteers.
    Ragueneau I; Sao AB; Démolis JL; Darné B; Funck-Brentano C; Jaillon P
    Clin Pharmacol Ther; 2001 Mar; 69(3):122-9. PubMed ID: 11240976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.
    Lamarre-Cliche M; Souich Pd; Champlain Jd; Larochelle P
    Clin Ther; 2008 Sep; 30(9):1629-38. PubMed ID: 18840368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of eprosartan on catecholamines and peripheral haemodynamics in subjects with insulin-induced hypoglycaemia.
    Christensen M; Ibsen H; Worck R
    Clin Sci (Lond); 2005 Feb; 108(2):113-9. PubMed ID: 15383007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endogenous opiate peptides may limit norepinephrine release during hemorrhage.
    Schadt JC; Gaddis RR
    J Pharmacol Exp Ther; 1985 Mar; 232(3):656-60. PubMed ID: 3973823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of snuff entails lower risk of cardiovascular diseases than does smoking].
    Asplund K
    Lakartidningen; 2003 Jun; 100(25):2206-10. PubMed ID: 12872508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of the use of oral snuff.
    Hirsch JM; Hedner J; Wernstedt L; Lundberg J; Hedner T
    Clin Pharmacol Ther; 1992 Oct; 52(4):394-401. PubMed ID: 1424411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Overview of knowledge of health effects of smokeless tobacco. Increased risk of cardiovascular diseases and mortality because of snuff].
    Bolinder G
    Lakartidningen; 1997 Oct; 94(42):3725-31. PubMed ID: 9411127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute effects of ephedra on autonomic nervous modulation in healthy young adults.
    Chen WL; Tsai TH; Yang CC; Kuo TB
    Clin Pharmacol Ther; 2010 Jul; 88(1):39-44. PubMed ID: 20520603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Smokeless tobacco and cardiovascular disease.
    Asplund K
    Prog Cardiovasc Dis; 2003; 45(5):383-94. PubMed ID: 12704595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.